Y Mabs Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $195k | 12k | 16.26 |
| 2023-12-31 | $71k | 10k | 6.82 |
| 2023-09-30 | $45k | 8.2k | 5.45 |
| 2023-06-30 | $99k | 15k | 6.79 |
| 2022-09-30 | $18k | 1.3k | 13.87 |
| 2022-06-30 | $24k | 1.5k | 15.56 |
| 2022-03-31 | $212k | 18k | 11.85 |
| 2021-12-31 | $852k | 29k | 29.41 |
| 2021-09-30 | $1.8M | 42k | 41.67 |
| 2021-06-30 | $692k | 17k | 41.67 |
| 2021-03-31 | $434k | 14k | 30.21 |
| 2020-12-31 | $1.3M | 27k | 49.30 |
| 2020-09-30 | $635k | 16k | 38.63 |
| 2020-06-30 | $791k | 18k | 43.18 |
| 2020-03-31 | $329k | 13k | 26.12 |
| 2019-12-31 | $343k | 11k | 31.22 |
| 2019-09-30 | $694k | 27k | 26.03 |
| 2019-06-30 | $439k | 19k | 22.84 |
| 2019-03-31 | $96k | 3.7k | 26.11 |
| 2018-12-31 | $70k | 3.6k | 19.44 |